Research

Optimisation of tetrahydroisoquinoline based microtubule disruptors as anti-cancer agents


Reference:

Leese, M. P., Jourdan, F., Ferrandis, E., Regis-Lydi, S., Kasprzyk, P. G., Stengel, C., Newman, S. P., Purohit, A., Reed, M. J. and Potter, B. V. L., 2010. Optimisation of tetrahydroisoquinoline based microtubule disruptors as anti-cancer agents. EJC Supplements, 8 (7), p. 141.

Related documents:

This repository does not currently have the full-text of this item.
You may be able to access a copy if URLs are provided below. (Contact Author)

Official URL:

http://dx.doi.org/10.1016/S1359-6349(10)72153-4

Details

Item Type Articles
CreatorsLeese, M. P., Jourdan, F., Ferrandis, E., Regis-Lydi, S., Kasprzyk, P. G., Stengel, C., Newman, S. P., Purohit, A., Reed, M. J. and Potter, B. V. L.
DOI10.1016/S1359-6349(10)72153-4
DepartmentsFaculty of Science > Pharmacy & Pharmacology
RefereedNo
StatusPublished
ID Code23294
Additional InformationMeeting abstract from 22nd EORTC NCI AACR Symposium on Molecular Targets and Cancer Therapeutics. 16-19 November 2010. Berlin, Germany.

Export

Actions (login required)

View Item